+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bioresorbable Polymers Market - Global Forecast 2026-2032- Product Image
Bioresorbable Polymers Market - Global Forecast 2026-2032- Product Image
Sale

Bioresorbable Polymers Market - Global Forecast 2026-2032

  • Report

  • 195 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 6010901
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Bioresorbable Polymers Market is projected to reach USD 1.19 Billion in 2026. It is expected to continue growing at a CAGR of 11.00%, reaching USD 2.26 Billion by 2032.

Bioresorbable polymers are engineered materials designed to perform a temporary clinical or functional role and then degrade into biocompatible byproducts that can be metabolized or safely eliminated. In healthcare, these polymers are widely used in absorbable sutures, orthopedic fixation devices, drug delivery systems, tissue engineering scaffolds, wound closure products, and next-generation cardiovascular implants.

Market momentum is supported by the global shift toward minimally invasive procedures, patient-specific care, and medical devices that reduce the need for secondary removal surgery. Materials such as polylactic acid, polyglycolic acid, polycaprolactone, and copolymers including PLGA remain central to product development because their degradation behavior, mechanical properties, and processing characteristics are well documented across regulated medical applications.

For industry leaders, the bioresorbable polymers market is increasingly defined by clinical evidence, regulatory confidence, supply chain reliability, and the ability to align material performance with end-use requirements. Organizations that combine polymer science, device design, sterilization validation, quality systems, and post-market surveillance are best positioned to address long-term demand in medical-grade bioresorbable materials.

Transformative Shifts Reshaping Market Demand

The landscape is shifting from commodity absorbable materials toward high-performance, application-specific bioresorbable polymer platforms. Medical device manufacturers are demanding tighter control over molecular weight, crystallinity, degradation rate, residual monomers, mechanical retention, and sterilization tolerance to support increasingly complex implants and drug-device combinations.

A second major shift is the movement from permanent implants to temporary therapeutic solutions. Orthopedics, sports medicine, cardiovascular care, dental surgery, soft-tissue repair, and regenerative medicine are evaluating materials that provide structural support during healing and then resorb, potentially reducing long-term foreign body burden and device-removal procedures.

Sustainability, biocompatibility, and traceability are also influencing procurement and innovation decisions. While medical-grade performance remains the priority, manufacturers are paying closer attention to solvent use, raw material provenance, extractables and leachables, sterilization compatibility, and compliance with evolving quality and safety expectations across major regulatory markets.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is becoming a practical accelerator in bioresorbable polymer research, especially in material screening, formulation optimization, and degradation modeling. Machine learning tools can analyze relationships among monomer composition, processing parameters, morphology, mechanical strength, and hydrolysis behavior to shorten development cycles and reduce experimental burden.

AI is also improving medical device design by supporting simulation-led engineering, image-based anatomical modeling, and predictive performance analysis. For customized implants and tissue scaffolds, AI-enabled workflows can help match pore architecture, degradation rate, mechanical retention, and load-bearing requirements to patient or procedure needs.

The cumulative impact is not limited to R&D. AI-supported quality analytics, process monitoring, batch deviation detection, and adverse event signal analysis can strengthen manufacturing consistency and post-market vigilance. However, adoption must be governed by validated datasets, explainable models, cybersecurity controls, human oversight, and regulatory documentation suitable for medical-grade decision-making.

Key Regional Insights Across Global Markets

Asia-Pacific is gaining strategic importance as China, India, Japan, South Korea, and Australia expand advanced medical manufacturing, clinical research capacity, and demand for absorbable surgical, orthopedic, dental, and wound care products. The region benefits from large patient populations, rising procedure volumes, aging demographics, and government support for domestic medtech capabilities, while Japan and South Korea remain important centers for high-quality device engineering and precision manufacturing.

North America continues to lead in premium medical device innovation, supported by a mature regulatory pathway, strong venture financing, university research, established hospital networks, and advanced orthopedic, cardiovascular, and wound care markets. Europe remains highly influential through CE-marked device development, stricter clinical evaluation requirements, and strong polymer and specialty materials expertise across Germany, France, Italy, Spain, and the United Kingdom.

Latin America is an emerging demand center led by Brazil and Mexico, where hospital modernization, private healthcare expansion, and access to surgical care are improving. The Middle East is expanding through healthcare infrastructure investment, especially in GCC markets pursuing advanced specialty care and medical tourism, while Africa represents a longer-term opportunity linked to surgical capacity expansion, public health investment, and access to cost-effective absorbable medical products.

Key Group Insights for Strategic Positioning

ASEAN is becoming relevant as a manufacturing and healthcare access corridor, with Singapore, Malaysia, Thailand, Vietnam, and Indonesia supporting medical device production, regional distribution, clinical service expansion, and hospital modernization. Demand is shaped by cost-sensitive procurement, rising surgical volumes, and interest in reliable absorbable products for wound closure, dental care, and orthopedic procedures.

The GCC is advancing through high-value healthcare investment, medical tourism strategies, and modernization of hospital systems, creating opportunities for premium bioresorbable implants, surgical consumables, and drug delivery technologies. The European Union remains a critical regulatory and commercial bloc because MDR compliance, clinical evidence expectations, post-market surveillance obligations, and harmonized market access strongly influence global device development strategies.

BRICS economies offer scale, domestic manufacturing ambitions, expanding hospital access, and policy support for localized healthcare production, although pricing pressure and regulatory complexity vary by country. G7 markets remain central to innovation, reimbursement, clinical adoption, and advanced research, while NATO-aligned supply chains increasingly prioritize resilience, traceability, quality assurance, and trusted sourcing for critical medical materials.

Key Country Insights for Bioresorbable Polymer Adoption

The United States is the most influential country market due to its concentration of medical device developers, regulated absorbable technologies, clinical trial infrastructure, high procedure volumes, and broad adoption of advanced orthopedic, cardiovascular, and wound care solutions. Canada offers stable demand, universal healthcare access, and strong academic research, while Mexico combines rising healthcare access with an important role in North American medical device manufacturing and export-oriented production.

Brazil is Latin America’s leading opportunity, supported by a large healthcare system, expanding private care, and growing surgical demand. In Europe, the United Kingdom, Germany, France, Italy, and Spain are important adopters of advanced medical technologies, with Germany standing out for engineering depth and polymer processing capability, France and the United Kingdom contributing strong clinical and research ecosystems, and Italy and Spain supporting demand through established surgical and hospital networks. Russia presents demand potential but is affected by geopolitical, regulatory, payment, and supply chain constraints.

China and India are high-potential markets driven by large patient bases, domestic medtech policies, expanding hospital infrastructure, and increasing use of advanced surgical products. Japan emphasizes quality, safety, aging-care needs, and precision engineering; South Korea is strong in medical innovation, manufacturing, and digital health integration; and Australia offers a sophisticated regulatory environment, strong clinical standards, and demand for clinically validated absorbable solutions.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize application-specific polymer platforms rather than broad material portfolios. The strongest competitive positions will come from matching degradation kinetics, mechanical retention, sterilization compatibility, biocompatibility, and processing performance to clearly defined clinical use cases.

Organizations should invest in clinical evidence, regulatory readiness, and supplier qualification early in development. Medical-grade bioresorbable polymers require documented biocompatibility, extractables and leachables assessment, residual control, validated sterilization, and consistent manufacturing quality to support device approvals and customer confidence.

Strategic partnerships with device manufacturers, contract development organizations, hospitals, and academic laboratories can accelerate commercialization. Leaders should also build AI-enabled formulation and process analytics, diversify critical monomer and polymer supply, establish contingency sourcing, and create regional market access plans that reflect reimbursement, clinician adoption, and local regulatory requirements.

Research Methodology

This executive summary is developed using a structured secondary research approach aligned with market intelligence best practices. Inputs include publicly available regulatory guidance, medical device approval databases, peer-reviewed scientific literature, standards-based quality expectations, government healthcare publications, trade data indicators, and macroeconomic factors relevant to healthcare demand and manufacturing capacity.

The analysis triangulates material trends, clinical applications, regional healthcare investment, regulatory developments, and supply chain indicators to identify validated demand drivers and market constraints. Emphasis is placed on evidence-backed insights rather than speculative projections, with attention to the practical realities of medical-grade polymer qualification, device commercialization, sterilization validation, and post-market compliance.

Country, regional, and group-level findings are interpreted through adoption readiness, manufacturing capability, healthcare infrastructure, regulatory maturity, clinical evidence requirements, and end-user demand. This methodology supports market context while maintaining an authoritative and data-grounded perspective for strategic decision-makers.

Conclusion and Strategic Outlook

The bioresorbable polymers market is evolving from a niche material category into a strategic foundation for advanced medical devices, controlled drug delivery, and regenerative medicine. Demand is being shaped by the need for temporary implants, improved patient outcomes, reduced revision procedures, and materials that can be engineered for precise degradation and performance.

Future competitiveness will depend on the ability to combine polymer chemistry with clinical validation, regulatory discipline, scalable manufacturing, and data-driven product development. Organizations that align material innovation with real procedural needs and regional market access requirements will be best positioned to strengthen adoption.

As AI, personalized medicine, minimally invasive care, and tissue engineering continue to converge, bioresorbable polymers are expected to remain central to next-generation healthcare innovation. The market favors organizations that can deliver safety, consistency, traceability, and measurable clinical value at scale.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Bioresorbable Polymers Market, by Product
7.1. Introduction
7.2. Fibers
7.3. Films
7.4. Micro-Particles
7.5. Nanomaterials
8. Bioresorbable Polymers Market, by Form
8.1. Introduction
8.2. Liquid
8.3. Powder
8.4. Solid
9. Bioresorbable Polymers Market, by Manufacturing Process
9.1. Introduction
9.2. Blow Molding
9.3. Extrusion
9.4. Injection Molding
10. Bioresorbable Polymers Market, by Material Type
10.1. Introduction
10.2. Polyanhydrides
10.3. Polycaprolactone (PCL)
10.4. Polyglycolic Acid (PGA)
10.5. Polyhydroxyalkanoate (PHA)
10.6. Polylactic Acid (PLA)
11. Bioresorbable Polymers Market, by Application
11.1. Introduction
11.2. Drug Delivery Systems
11.2.1. Controlled Release Formulations
11.2.2. Target-Specific Vehicles
11.3. Medical Implants
11.3.1. Cardiovascular Stents
11.3.2. Orthopedic Implants
11.4. Tissue Engineering
11.4.1. Scaffold Designs
11.4.2. Stem Cell Scaffolding
11.5. Wound Healing Devices
11.5.1. Adhesive Solutions
11.5.2. Bandaging Materials
12. Bioresorbable Polymers Market, by End-User
12.1. Introduction
12.2. Biotechnology Companies
12.3. Hospitals and Clinics
12.4. Pharmaceutical Companies
12.5. Research Institutes
13. Bioresorbable Polymers Market, by Region
13.1. Asia-Pacific
13.2. North America
13.3. Latin America
13.4. Europe
13.5. Middle East
13.6. Africa
14. Bioresorbable Polymers Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Bioresorbable Polymers Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. FPNV Positioning Matrix, 2025
16.3. Market Concentration Analysis, 2025
16.3.1. Concentration Ratio (CR)
16.3.2. Herfindahl Hirschman Index (HHI)
16.4. Recent Developments & Impact Analysis, 2025
16.5. Product Portfolio Analysis, 2025
16.6. Benchmarking Analysis, 2025
17. Company Profiles
17.1. 3D Biotek LLC
17.2. Acuro Organics Limited
17.3. Advanced Polymer Materials Inc.
17.4. Anhui Jumei Biological Technology Co., Ltd.
17.5. Ashland Inc.
17.6. Avantium N.V.
17.7. BMG Incorporated
17.8. CD Bioparticles
17.9. Corbion NV
17.10. Evonik Industries AG
17.11. Foster Corporation
17.12. Futerro Group
17.13. Galatea Surgical, Inc.
17.14. Huizhou Foryou Medical Devices Co., Ltd.
17.15. Koninklijke DSM N.V.
17.16. MAST Biosurgery
17.17. Merck KGaA
17.18. Mitsui & Co., Ltd.
17.19. Nanosoft Polymers
17.20. Nomisma Healthcare Pvt. Ltd.
17.21. Otto Chemie Pvt. Ltd.
17.22. Poly-Med Incorporated
17.23. PolyNovo Limited
17.24. Polysciences, Inc.
17.25. REVA Medical, LLC
17.26. Rivika Bio Industries Pvt. Ltd.
17.27. SEQENS SAS
17.28. Solanyl Biopolymers Inc.
17.29. SpecialChem S.A.
17.30. Torise Biomaterials Co.,Ltd.
List of Figures
FIGURE 1. GLOBAL BIORESORBABLE POLYMERS MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL BIORESORBABLE POLYMERS MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL BIORESORBABLE POLYMERS MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL BIORESORBABLE POLYMERS MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2025 VS 2032 (%)
FIGURE 7. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2025 VS 2032 (%)
FIGURE 9. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2025 VS 2032 (%)
FIGURE 11. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2032 (%)
FIGURE 13. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 15. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2025 VS 2032 (%)
FIGURE 17. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 19. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 21. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 23. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL BIORESORBABLE POLYMERS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 25. GLOBAL BIORESORBABLE POLYMERS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL BIORESORBABLE POLYMERS MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL FIBERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL FIBERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL FIBERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL FILMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL FILMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL FILMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL MICRO-PARTICLES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL MICRO-PARTICLES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL MICRO-PARTICLES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL NANOMATERIALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL NANOMATERIALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL NANOMATERIALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL LIQUID MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL LIQUID MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL LIQUID MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL POWDER MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL POWDER MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL POWDER MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL SOLID MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL SOLID MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL SOLID MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL BLOW MOLDING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL BLOW MOLDING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL BLOW MOLDING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL EXTRUSION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL EXTRUSION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL EXTRUSION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL INJECTION MOLDING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL INJECTION MOLDING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL INJECTION MOLDING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL POLYANHYDRIDES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL POLYANHYDRIDES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL POLYANHYDRIDES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL POLYCAPROLACTONE (PCL) MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL POLYCAPROLACTONE (PCL) MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL POLYCAPROLACTONE (PCL) MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL POLYGLYCOLIC ACID (PGA) MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL POLYGLYCOLIC ACID (PGA) MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL POLYGLYCOLIC ACID (PGA) MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL POLYHYDROXYALKANOATE (PHA) MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL POLYHYDROXYALKANOATE (PHA) MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL POLYHYDROXYALKANOATE (PHA) MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL POLYLACTIC ACID (PLA) MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL POLYLACTIC ACID (PLA) MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL POLYLACTIC ACID (PLA) MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL CONTROLLED RELEASE FORMULATIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL CONTROLLED RELEASE FORMULATIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL CONTROLLED RELEASE FORMULATIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL TARGET-SPECIFIC VEHICLES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL TARGET-SPECIFIC VEHICLES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL TARGET-SPECIFIC VEHICLES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL CARDIOVASCULAR STENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL CARDIOVASCULAR STENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL CARDIOVASCULAR STENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL ORTHOPEDIC IMPLANTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL ORTHOPEDIC IMPLANTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL ORTHOPEDIC IMPLANTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL SCAFFOLD DESIGNS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL SCAFFOLD DESIGNS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL SCAFFOLD DESIGNS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL STEM CELL SCAFFOLDING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL STEM CELL SCAFFOLDING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL STEM CELL SCAFFOLDING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL WOUND HEALING DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL WOUND HEALING DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL WOUND HEALING DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL ADHESIVE SOLUTIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL ADHESIVE SOLUTIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL ADHESIVE SOLUTIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL BANDAGING MATERIALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL BANDAGING MATERIALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL BANDAGING MATERIALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL BIOTECHNOLOGY COMPANIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL BIOTECHNOLOGY COMPANIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL BIOTECHNOLOGY COMPANIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL HOSPITALS AND CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL HOSPITALS AND CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL HOSPITALS AND CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL PHARMACEUTICAL COMPANIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL PHARMACEUTICAL COMPANIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL PHARMACEUTICAL COMPANIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 103. ASIA-PACIFIC BIORESORBABLE POLYMERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 104. ASIA-PACIFIC BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 105. ASIA-PACIFIC BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 106. ASIA-PACIFIC BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2017-2032 (USD MILLION)
TABLE 107. ASIA-PACIFIC BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 108. ASIA-PACIFIC BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 109. ASIA-PACIFIC BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2017-2032 (USD MILLION)
TABLE 110. ASIA-PACIFIC BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2017-2032 (USD MILLION)
TABLE 111. ASIA-PACIFIC BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2017-2032 (USD MILLION)
TABLE 112. ASIA-PACIFIC BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2017-2032 (USD MILLION)
TABLE 113. ASIA-PACIFIC BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 114. NORTH AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 115. NORTH AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 116. NORTH AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 117. NORTH AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2017-2032 (USD MILLION)
TABLE 118. NORTH AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 119. NORTH AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 120. NORTH AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2017-2032 (USD MILLION)
TABLE 121. NORTH AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2017-2032 (USD MILLION)
TABLE 122. NORTH AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2017-2032 (USD MILLION)
TABLE 123. NORTH AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2017-2032 (USD MILLION)
TABLE 124. NORTH AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 125. LATIN AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 126. LATIN AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 127. LATIN AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 128. LATIN AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2017-2032 (USD MILLION)
TABLE 129. LATIN AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 130. LATIN AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 131. LATIN AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2017-2032 (USD MILLION)
TABLE 132. LATIN AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2017-2032 (USD MILLION)
TABLE 133. LATIN AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2017-2032 (USD MILLION)
TABLE 134. LATIN AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2017-2032 (USD MILLION)
TABLE 135. LATIN AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 136. EUROPE BIORESORBABLE POLYMERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 137. EUROPE BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 138. EUROPE BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 139. EUROPE BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2017-2032 (USD MILLION)
TABLE 140. EUROPE BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 141. EUROPE BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 142. EUROPE BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2017-2032 (USD MILLION)
TABLE 143. EUROPE BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2017-2032 (USD MILLION)
TABLE 144. EUROPE BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2017-2032 (USD MILLION)
TABLE 145. EUROPE BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2017-2032 (USD MILLION)
TABLE 146. EUROPE BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 147. MIDDLE EAST BIORESORBABLE POLYMERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 148. MIDDLE EAST BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 149. MIDDLE EAST BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 150. MIDDLE EAST BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2017-2032 (USD MILLION)
TABLE 151. MIDDLE EAST BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 152. MIDDLE EAST BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 153. MIDDLE EAST BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2017-2032 (USD MILLION)
TABLE 154. MIDDLE EAST BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2017-2032 (USD MILLION)
TABLE 155. MIDDLE EAST BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2017-2032 (USD MILLION)
TABLE 156. MIDDLE EAST BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2017-2032 (USD MILLION)
TABLE 157. MIDDLE EAST BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 158. AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 159. AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 160. AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 161. AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2017-2032 (USD MILLION)
TABLE 162. AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 163. AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 164. AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2017-2032 (USD MILLION)
TABLE 165. AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2017-2032 (USD MILLION)
TABLE 166. AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2017-2032 (USD MILLION)
TABLE 167. AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2017-2032 (USD MILLION)
TABLE 168. AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 169. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 170. ASEAN BIORESORBABLE POLYMERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 171. ASEAN BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 172. ASEAN BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 173. ASEAN BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2017-2032 (USD MILLION)
TABLE 174. ASEAN BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 175. ASEAN BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 176. ASEAN BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2017-2032 (USD MILLION)
TABLE 177. ASEAN BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2017-2032 (USD MILLION)
TABLE 178. ASEAN BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2017-2032 (USD MILLION)
TABLE 179. ASEAN BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2017-2032 (USD MILLION)
TABLE 180. ASEAN BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 181. GCC BIORESORBABLE POLYMERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 182. GCC BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 183. GCC BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 184. GCC BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2017-2032 (USD MILLION)
TABLE 185. GCC BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 186. GCC BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 187. GCC BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2017-2032 (USD MILLION)
TABLE 188. GCC BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2017-2032 (USD MILLION)
TABLE 189. GCC BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2017-2032 (USD MILLION)
TABLE 190. GCC BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2017-2032 (USD MILLION)
TABLE 191. GCC BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 192. EUROPEAN UNION BIORESORBABLE POLYMERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 193. EUROPEAN UNION BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 194. EUROPEAN UNION BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 195. EUROPEAN UNION BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2017-2032 (USD MILLION)
TABLE 196. EUROPEAN UNION BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 197. EUROPEAN UNION BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 198. EUROPEAN UNION BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2017-2032 (USD MILLION)
TABLE 199. EUROPEAN UNION BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2017-2032 (USD MILLION)
TABLE 200. EUROPEAN UNION BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2017-2032 (USD MILLION)
TABLE 201. EUROPEAN UNION BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2017-2032 (USD MILLION)
TABLE 202. EUROPEAN UNION BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 203. BRICS BIORESORBABLE POLYMERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 204. BRICS BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 205. BRICS BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 206. BRICS BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2017-2032 (USD MILLION)
TABLE 207. BRICS BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 208. BRICS BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 209. BRICS BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2017-2032 (USD MILLION)
TABLE 210. BRICS BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2017-2032 (USD MILLION)
TABLE 211. BRICS BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2017-2032 (USD MILLION)
TABLE 212. BRICS BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2017-2032 (USD MILLION)
TABLE 213. BRICS BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 214. G7 BIORESORBABLE POLYMERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 215. G7 BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 216. G7 BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 217. G7 BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2017-2032 (USD MILLION)
TABLE 218. G7 BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 219. G7 BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 220. G7 BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2017-2032 (USD MILLION)
TABLE 221. G7 BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2017-2032 (USD MILLION)
TABLE 222. G7 BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2017-2032 (USD MILLION)
TABLE 223. G7 BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2017-2032 (USD MILLION)
TABLE 224. G7 BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 225. NATO BIORESORBABLE POLYMERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 226. NATO BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 227. NATO BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 228. NATO BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2017-2032 (USD MILLION)
TABLE 229. NATO BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 230. NATO BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 231. NATO BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2017-2032 (USD MILLION)
TABLE 232. NATO BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2017-2032 (USD MILLION)
TABLE 233. NATO BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2017-2032 (USD MILLION)
TABLE 234. NATO BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2017-2032 (USD MILLION)
TABLE 235. NATO BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 236. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 237. UNITED STATES BIORESORBABLE POLYMERS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 238. UNITED STATES BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 239. UNITED STATES BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 240. UNITED STATES BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2017-2032 (USD MILLION)
TABLE 241. UNITED STATES BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 242. UNITED STATES BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 243. UNITED STATES BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2017-2032 (USD MILLION)
TABLE 244. UNITED STATES BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2017-2032 (USD MILLION)
TABLE 245. UNITED STATES BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2017-2032 (USD MILLION)
TABLE 246. UNITED STATES BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2017-2032 (USD MILLION)
TABLE 247. UNITED STATES BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 248. CANADA BIORESORBABLE POLYMERS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 249. CANADA BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 250. CANADA BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 251. CANADA BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2017-2032 (USD MILLION)
TABLE 252. CANADA BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 253. CANADA BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 254. CANADA BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2017-2032 (USD MILLION)
TABLE 255. CANADA BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2017-2032 (USD MILLION)
TABLE 256. CANADA BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2017-2032 (USD MILLION)
TABLE 257. CANADA BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2017-2032 (USD MILLION)
TABLE 258. CANADA BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 259. MEXICO BIORESORBABLE POLYMERS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 260. MEXICO BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 261. MEXICO BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 262. MEXICO BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2017-2032 (USD MILLION)
TABLE 263. MEXICO BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 264. MEXICO BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 265. MEXICO BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2017-2032 (USD MILLION)
TABLE 266. MEXICO BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2017-2032 (USD MILLION)
TABLE 267. MEXICO BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2017-2032 (USD MILLION)
TABLE 268. MEXICO BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2017-2032 (USD MILLION)
TABLE 269. MEXICO BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 270. BRAZIL BIORESORBABLE POLYMERS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 271. BRAZIL BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 272. BRAZIL BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 273. BRAZIL BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2017-2032 (USD MILLION)
TABLE 274. BRAZIL BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 275. BRAZIL BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 276. BRAZIL BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2017-2032 (USD MILLION)
TABLE 277. BRAZIL BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2017-2032 (USD MILLION)
TABLE 278. BRAZIL BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2017-2032 (USD MILLION)
TABLE 279. BRAZIL BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2017-2032 (USD MILLION)
TABLE 280. BRAZIL BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 281. UNITED KINGDOM BIORESORBABLE POLYMERS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 282. UNITED KINGDOM BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 283. UNITED KINGDOM BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 284. UNITED KINGDOM BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2017-2032 (USD MILLION)
TABLE 285. UNITED KINGDOM BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 286. UNITED KINGDOM BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 287. UNITED KINGDOM BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2017-2032 (USD MILLION)
TABLE 288. UNITED KINGDOM BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2017-2032 (USD MILLION)
TABLE 289. UNITED KINGDOM BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2017-2032 (USD MILLION)
TABLE 290. UNITED KINGDOM BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2017-2032 (USD MILLION)
TABLE 291. UNITED KINGDOM BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 292. GERMANY BIORESORBABLE POLYMERS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 293. GERMANY BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 294. GERMANY BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 295. GERMANY BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2017-2032 (USD MILLION)
TABLE 296. GERMANY BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 297. GERMANY BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 298. GERMANY BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2017-2032 (USD MILLION)
TABLE 299. GERMANY BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2017-2032 (USD MILLION)
TABLE 300. GERMANY BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2017-2032 (USD MILLION)
TABLE 301. GERMANY BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2017-2032 (USD MILLION)
TABLE 302. GERMANY BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 303. FRANCE BIORESORBABLE POLYMERS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 304. FRANCE BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 305. FRANCE BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 306. FRANCE BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2017-2032 (USD MILLION)
TABLE 307. FRANCE BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 308. FRANCE BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 309. FRANCE BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2017-2032 (USD MILLION)
TABLE 310. FRANCE BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2017-2032 (USD MILLION)
TABLE 311. FRANCE BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2017-2032 (USD MILLION)
TABLE 312. FRANCE BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2017-2032 (USD MILLION)
TABLE 313. FRANCE BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 314. RUSSIA BIORESORBABLE POLYMERS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 315. RUSSIA BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 316. RUSSIA BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 317. RUSSIA BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2017-2032 (USD MILLION)
TABLE 318. RUSSIA BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 319. RUSSIA BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 320. RUSSIA BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2017-2032 (USD MILLION)
TABLE 321. RUSSIA BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2017-2032 (USD MILLION)
TABLE 322. RUSSIA BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2017-2032 (USD MILLION)
TABLE 323. RUSSIA BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2017-2032 (USD MILLION)
TABLE 324. RUSSIA BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 325. ITALY BIORESORBABLE POLYMERS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 326. ITALY BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 327. ITALY BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 328. ITALY BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2017-2032 (USD MILLION)
TABLE 329. ITALY BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 330. ITALY BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 331. ITALY BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2017-2032 (USD MILLION)
TABLE 332. ITALY BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2017-2032 (USD MILLION)
TABLE 333. ITALY BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2017-2032 (USD MILLION)
TABLE 334. ITALY BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2017-2032 (USD MILLION)
TABLE 335. ITALY BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 336. SPAIN BIORESORBABLE POLYMERS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 337. SPAIN BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 338. SPAIN BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 339. SPAIN BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2017-2032 (USD MILLION)
TABLE 340. SPAIN BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 341. SPAIN BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 342. SPAIN BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2017-2032 (USD MILLION)
TABLE 343. SPAIN BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2017-2032 (USD MILLION)
TABLE 344. SPAIN BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2017-2032 (USD MILLION)
TABLE 345. SPAIN BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2017-2032 (USD MILLION)
TABLE 346. SPAIN BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 347. CHINA BIORESORBABLE POLYMERS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 348. CHINA BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 349. CHINA BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 350. CHINA BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2017-2032 (USD MILLION)
TABLE 351. CHINA BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 352. CHINA BIORESORBABLE POLYMERS

Companies Mentioned

  • 3D Biotek LLC
  • Acuro Organics Limited
  • Advanced Polymer Materials Inc.
  • Anhui Jumei Biological Technology Co., Ltd.
  • Ashland Inc.
  • Avantium N.V.
  • BMG Incorporated
  • CD Bioparticles
  • Corbion NV
  • Evonik Industries AG
  • Foster Corporation
  • Futerro Group
  • Galatea Surgical, Inc.
  • Huizhou Foryou Medical Devices Co., Ltd.
  • Koninklijke DSM N.V.
  • MAST Biosurgery
  • Merck KGaA
  • Mitsui & Co., Ltd.
  • Nanosoft Polymers
  • Nomisma Healthcare Pvt. Ltd.
  • Otto Chemie Pvt. Ltd.
  • Poly-Med Incorporated
  • PolyNovo Limited
  • Polysciences, Inc.
  • REVA Medical, LLC
  • Rivika Bio Industries Pvt. Ltd.
  • SEQENS SAS
  • Solanyl Biopolymers Inc.
  • SpecialChem S.A.
  • Torise Biomaterials Co.,Ltd.

Table Information

Report AttributeDetails
No. of Pages195
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 1.19 Billion
Forecasted Market Value ( USD ) by 2032 $ 2.26 Billion
Compound Annual Growth Rate11.0%
Regions CoveredGlobal
No. of Companies Mentioned30

Related Topics

Related Reports

Bioresorbable (Resorbable) Polymers - Global Strategic Business Report - Product Image

Bioresorbable (Resorbable) Polymers - Global Strategic Business Report

  • Report
  • 152 Pages
  • Global
From
Resorbable (Bioresorbable) Polymers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 - Product Image

Resorbable (Bioresorbable) Polymers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

  • Report
  • 180 Pages
  • Global
From
2026 Bioresorbable (Resorbable) Polymers Market Outlook: Size, Trends and Forecast 2025-2034 - Product Image

2026 Bioresorbable (Resorbable) Polymers Market Outlook: Size, Trends and Forecast 2025-2034

  • Report
  • 160 Pages
  • Global
From
Bioresorbable Polymers Market - Global Strategic Business Report - Product Image

Bioresorbable Polymers Market - Global Strategic Business Report

  • Report
  • 271 Pages
  • Global
From
Polymer Biomaterial Market Outlook 2025-2034: Market Share, and Growth Analysis - Product Image

Polymer Biomaterial Market Outlook 2025-2034: Market Share, and Growth Analysis

  • Report
  • 160 Pages
  • Global
From

About the Bioresorbable Polymer Market

Bioresorbable polymers are a type of plastic that can be broken down by the body's natural processes. They are used in medical applications such as drug delivery, tissue engineering, and wound healing. They are also used in the food industry for packaging and in the automotive industry for parts. Bioresorbable polymers are advantageous because they are biocompatible, biodegradable, and non-toxic. They are also cost-effective and can be tailored to meet specific needs. Some companies in the bioresorbable polymer market include BASF, Evonik, Corbion, and PolyOne. These companies produce a variety of bioresorbable polymers for medical, food, and automotive applications. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.